首页>
外国专利>
1-(2,3-dihydro-1,4-benzodioxin-2-yl)-methanamine derivatives for the modulation of dopaminergic function in the central nervous system
1-(2,3-dihydro-1,4-benzodioxin-2-yl)-methanamine derivatives for the modulation of dopaminergic function in the central nervous system
展开▼
机译:1-(2,3-二氢-1,4-苯并二恶英-2-基)-甲胺衍生物可调节中枢神经系统的多巴胺能
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed are 1-(2,3-dihydro-1,4-benzodioxin-2-yl)-methanamine derivatives of Formula 1, stereoisomers and salts thereof, and methods for their preparation. Specific examples of compounds of formula 1 include: N-{ [7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} -propan-1-amine; 2-Methyl-N-{ [(2R)-7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} propan-1-amine, 2-Methyl-N-{ [7-(methylsulfony)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} propan-1-amine, and N-{ [(2S)-5-Chloro-7-(methylsulfonyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl} -N-propylpropan-1amine. Compounds of formula 1 are useful for treating diseases, disorders or conditions responsive to modulation of dopaminergic function in the central nervous system, such as movement disorders, Parkinson's disease, Parkinsonism, dyskinesias, L-DOPA induced dyskinesias, dystonias, tics, tremor, Huntington's disease, iatrogenic psychoses and hallucinoses, non-iatrogenic psychoses and hallucinoses, schizophrenia, schizophreniform disorders, bipolar disorder, mood disorders, anxiety disorders, depression, obsessive-compulsive disease, neurodevelopmental disorders, Autism spectrum disorders, ADHD, Cerebral Palsy, Gilles de la Tourette's syndrome, neurodegenerative disorders, dementia, age-related cognitive impairment, sleep disorders, sexual disorders, eating disorders, obesitas, headaches, pains in conditions characterized by increased muscular tone, substance abuse, Alzheimer's disease or dementia disorders related to Alzheimer's disease.
展开▼